UPDATE – ASLAN Pharmaceuticals Temporarily Pauses Recruitment of New Patients Into ASLAN004 Study Due to COVID-19


You May Also Like

Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT

SUNNYVALE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical ...

Clearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs

ALPHARETTA, Ga., July 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...